|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
M.D. Anderson Cancer Center |
|---|---|
| Information provided by: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00501449 |
Purpose
The specific aims of the study include:
| Condition | Intervention |
|---|---|
|
Multiple Endocrine Neoplasia |
Behavioral: Questionnaire |
| Study Type: | Observational |
| Study Design: | Case-Only, Prospective |
| Official Title: | Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes |
| Estimated Enrollment: | 239 |
| Study Start Date: | May 2007 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
1
Patients with multiple endocrine neoplasia (MEN).
|
Behavioral: Questionnaire
Mailed packets including cover letter describing purpose of study, study questionnaire, and return envelope.
|
The proposed cross-sectional study is intended to obtain information regarding current surveillance behaviors and other psychosocial outcomes among persons affected by the multiple endocrine neoplasia (MEN) 1 or MEN2, which are inherited conditions.
Study participants will include patients who have been seen previously at MDACC for evaluation of MEN1 or MEN2. Because this is the first time investigators are contacting these patients to invite them to participate in psychosocial research, the proposed study also will help determine the feasibility of conducting similar studies in the future.
Investigators anticipate that data gathered from this study will enhance existing knowledge about the psychological and behavioral aspects of the MEN syndromes, and will inform future research efforts directed toward this understudied population.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with a diagnosis of MEN1 or MEN2.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Susan Peterson, PhD | 713-792-8267 |
| United States, Texas | |
| U.T.M.D. Anderson Cancer Center | Recruiting |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: Susan Peterson, PhD | |
| Principal Investigator: | Susan Peterson, PhD | U.T.M.D. Anderson Cancer Center |
More Information
| Responsible Party: | U.T.M.D. Anderson Cancer Center ( Susan Peterson, PhD/Assistant Professor ) |
| Study ID Numbers: | 2006-0783 |
| Study First Received: | July 12, 2007 |
| Last Updated: | December 30, 2008 |
| ClinicalTrials.gov Identifier: | NCT00501449 |
| Health Authority: | United States: Institutional Review Board |
|
Multiple Endocrine Neoplasia Questionnaire Psychosocial Surveillance Behaviors MEN Syndromes |
|
Neoplastic Syndromes, Hereditary Genetic Diseases, Inborn Endocrine System Diseases |
Endocrinopathy Multiple Endocrine Neoplasia Endocrine Gland Neoplasms |
|
Neoplasms Pathologic Processes Disease |
Neoplasms by Site Syndrome Neoplasms, Multiple Primary |
